These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A background and critical analysis of the treatment of pneumocystis carinii pneumonia (PCP) in HIV/AIDS. Mitchell B Aust Nurs J; 2007 Apr; 14(9):20-3. PubMed ID: 17441498 [No Abstract] [Full Text] [Related]
23. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Eldred LJ; Wu AW; Chaisson RE; Moore RD J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):117-25. PubMed ID: 9637576 [TBL] [Abstract][Full Text] [Related]
24. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. ; Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907 [No Abstract] [Full Text] [Related]
25. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations. Gaut P; Daar ES Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888 [No Abstract] [Full Text] [Related]
26. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham SM Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259 [No Abstract] [Full Text] [Related]
27. [Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS]. Arjol AM; Sánchez C; Dalmau D Enferm Infecc Microbiol Clin; 1998 May; 16(5):250-1. PubMed ID: 9666594 [No Abstract] [Full Text] [Related]
28. Alternative dapsone dosage regimen for prophylaxis of Pneumocystis carinii pneumonia. Gatti G; Fioredda F; Lorusso C; Cruciani M; Bassetti D Pediatr Infect Dis J; 1996 Feb; 15(2):183-4. PubMed ID: 8822303 [No Abstract] [Full Text] [Related]
29. Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Blanchet KD AIDS Patient Care STDS; 1996 Apr; 10(2):116-21. PubMed ID: 11361688 [No Abstract] [Full Text] [Related]
30. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection. Ungvarski P; Schmidt J Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201 [No Abstract] [Full Text] [Related]
31. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ; Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703 [TBL] [Abstract][Full Text] [Related]
32. Prevention and treatment of Pneumocystis pneumonia. Ong EL; Mandal BK N Engl J Med; 1993 May; 328(21):1569. PubMed ID: 8479504 [No Abstract] [Full Text] [Related]
33. Prevention and treatment of Pneumocystis pneumonia. Min DI; Noormohamed SE N Engl J Med; 1993 May; 328(21):1569. PubMed ID: 8192719 [No Abstract] [Full Text] [Related]
34. PCP prevention for children. Treat Rev; 1995 May; (no 18):9. PubMed ID: 11362597 [TBL] [Abstract][Full Text] [Related]
35. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Gill CJ; Sabin LL; Tham J; Hamer DH Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection. Mirochnick M; Cooper E; Capparelli E; McIntosh K; Lindsey J; Xu J; Jacobus D; Mofenson L; Bonagura VR; Nachman S; Yogev R; Sullivan JL; Spector SA Clin Pharmacol Ther; 2001 Jul; 70(1):24-32. PubMed ID: 11452241 [TBL] [Abstract][Full Text] [Related]